Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   168,823    

Indirect Shares

  417,826      
Direct Value   $5,035,310    

Indirect Value

  $13,780,226      
Total Shares   586,649      
Total Value   $18,815,536      


Agios Pharmaceuticals Inc
 $4,464,514 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,172 Denali Therapeutics Inc.
 $288,218 Regeneron Pharmaceuticals Inc
 $276,405 Agios Pharmaceuticals Inc
 $4,464,514 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,172 Denali Therapeutics Inc.
 $288,218 Regeneron Pharmaceuticals Inc
 $276,405
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 35.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2023-06-01 15,529 2023-06-01 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    153         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2019-02-19 4 D $58.03 $143,392 D/D (2,471) 89,503 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-04-03 4 OE $9.05 $148,085 D/D 16,363 134,242 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-05-01 4 AS $50.06 $150,180 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-07-03 4 AS $51.18 $153,540 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-01 4 AS $55.12 $165,360 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-04-03 4 AS $58.62 $175,860 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-01-17 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-01-30 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-02-13 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-02-27 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-03-27 4 OE $9.05 $181,000 D/D 20,000 137,879 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-08-11 4 AS $40.17 $181,970 I/I (4,530) 174,272 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2015-06-18 4 A $32.23 $193,283 D/D 5,997 11,251 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-12 4 AS $110.03 $230,293 I/I (2,093) 94,701 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-08-03 4 OE $0.30 $231,152 I/I 8,000 240,272 0 -
FMI Foundation Medicine, Inc. Director   –       •      –    2016-06-16 4 A $19.93 $240,655 D/D 12,075 23,326 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-09-05 4 OE $2.34 $249,028 D/D 75,119 75,119 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-09-10 4 OE $31.64 $276,217 D/D 8,730 83,849 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-03-05 4 AS $110.16 $286,416 I/I (2,600) 102,501 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-02-16 4 AS $50.01 $300,060 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-10-27 4 AS $80.26 $321,040 I/I (4,000) 232,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-08-01 4 AS $39.17 $331,770 I/I (8,470) 176,537 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-11 4 AS $110.01 $341,801 I/I (3,107) 96,794 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-04-01 4 AS $92.54 $360,906 I/I (3,900) 237,872 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-01 4 AS $93.63 $365,157 I/I (3,900) 231,372 0 -

  153  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed